tirzepatide us Yesterday the FDA approved for treatment under the name Zepbound; it's expected to be available in the U.S. by the end of the year and may be even more potent than Tirzepatide for Women's Weight Loss:

M.ThierR

This dual action appears to amplify appetite suppression and metabolic regulation beyond what GLP-1 activation alone produces, which is why clinical trials consistently show greater average weight loss with tirzepatide

It is known for its ability to regulate blood glucose levels , enhance insulin secretion , and support appetite control , making it an invaluable peptide in the exploration of novel therapies for diabetes and weight management

Warnings Hypersensitivity Reactions Serious hypersensitivity reactions, including rash, urticaria, and facial edema have been reported with oral Levocarnitine

For Canadians dealing with obesity and related metabolic conditions, this development matters because current options, while effective, still leave many patients short of their goals

Similarly, tirzepatide, a dual GLP-1R and GIP receptor agonist, does not seem to cross the BBB efficiently (Rhea et al., 2024)